110 related articles for article (PubMed ID: 22173128)
1. C-Kit controls IL-1β-induced effector functions in HMC-cells.
Drube S; Schmitz F; Göpfert C; Weber F; Kamradt T
Eur J Pharmacol; 2012 Jan; 675(1-3):57-62. PubMed ID: 22173128
[TBL] [Abstract][Full Text] [Related]
2. STI571 (Glivec) affects histamine release and intracellular pH after alkalinisation in HMC-1560, 816.
Löber K; Alfonso A; Escribano L; Botana LM
J Cell Biochem; 2008 Feb; 103(3):865-76. PubMed ID: 17615556
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of Kit expression by IL-4 and IL-10 in murine mast cells: role of STAT6 and phosphatidylinositol 3'-kinase.
Mirmonsef P; Shelburne CP; Fitzhugh Yeatman C; Chong HJ; Ryan JJ
J Immunol; 1999 Sep; 163(5):2530-9. PubMed ID: 10452990
[TBL] [Abstract][Full Text] [Related]
4. Baseline and stimulated turnover of cell surface c-Kit expression in different types of human mast cells.
Babina M; Rex C; Guhl S; Thienemann F; Artuc M; Henz BM; Zuberbier T
Exp Dermatol; 2006 Jul; 15(7):530-7. PubMed ID: 16761962
[TBL] [Abstract][Full Text] [Related]
5. Sensitivity of human cells bearing oncogenic mutant kit isoforms to the novel tyrosine kinase inhibitor INNO-406.
Pan J; Quintás-Cardama A; Manshouri T; Cortes J; Kantarjian H; Verstovsek S
Cancer Sci; 2007 Aug; 98(8):1223-5. PubMed ID: 17517053
[TBL] [Abstract][Full Text] [Related]
6. Effects of tyrosine kinase inhibitor STI571 on human mast cells bearing wild-type or mutated c-kit.
Akin C; Brockow K; D'Ambrosio C; Kirshenbaum AS; Ma Y; Longley BJ; Metcalfe DD
Exp Hematol; 2003 Aug; 31(8):686-92. PubMed ID: 12901973
[TBL] [Abstract][Full Text] [Related]
7. KIT polymorphisms and mutations determine responses of neoplastic mast cells to bafetinib (INNO-406).
Peter B; Hadzijusufovic E; Blatt K; Gleixner KV; Pickl WF; Thaiwong T; Yuzbasiyan-Gurkan V; Willmann M; Valent P
Exp Hematol; 2010 Sep; 38(9):782-91. PubMed ID: 20685234
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of c-kit tyrosine kinase by imatinib mesylate induces apoptosis in mast cells in rheumatoid synovia: a potential approach to the treatment of arthritis.
Juurikivi A; Sandler C; Lindstedt KA; Kovanen PT; Juutilainen T; Leskinen MJ; Mäki T; Eklund KK
Ann Rheum Dis; 2005 Aug; 64(8):1126-31. PubMed ID: 16014680
[TBL] [Abstract][Full Text] [Related]
9. Cross-talks between c-Kit and PKC isoforms in HMC-1(560) and HMC-1(560,816) cells. Different role of PKCδ in each cellular line.
Tobío A; Alfonso A; Botana LM
Cell Immunol; 2015 Feb; 293(2):104-12. PubMed ID: 25594139
[TBL] [Abstract][Full Text] [Related]
10. Steel factor-induced tyrosine phosphorylation in murine mast cells. Common elements with IL-3-induced signal transduction pathways.
Welham MJ; Schrader JW
J Immunol; 1992 Oct; 149(8):2772-83. PubMed ID: 1383327
[TBL] [Abstract][Full Text] [Related]
11. Stem cell factor and its receptor c-Kit as targets for inflammatory diseases.
Reber L; Da Silva CA; Frossard N
Eur J Pharmacol; 2006 Mar; 533(1-3):327-40. PubMed ID: 16483568
[TBL] [Abstract][Full Text] [Related]
12. Short-term and long-term cytokine release by mouse bone marrow mast cells and the differentiated KU-812 cell line are inhibited by brefeldin A.
Zhu FG; Gomi K; Marshall JS
J Immunol; 1998 Sep; 161(5):2541-51. PubMed ID: 9725254
[TBL] [Abstract][Full Text] [Related]
13. Regulation of mast cell characteristics by cytokines: divergent effects of interleukin-4 on immature mast cell lines versus mature human skin mast cells.
Thienemann F; Henz BM; Babina M
Arch Dermatol Res; 2004 Aug; 296(3):134-8. PubMed ID: 15322832
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-1beta stimulates acute phase response and C-reactive protein synthesis by inducing an NFkappaB- and C/EBPbeta-dependent autocrine interleukin-6 loop.
Kramer F; Torzewski J; Kamenz J; Veit K; Hombach V; Dedio J; Ivashchenko Y
Mol Immunol; 2008 May; 45(9):2678-89. PubMed ID: 18262272
[TBL] [Abstract][Full Text] [Related]
15. Niche anchorage and signaling through membrane-bound Kit-ligand/c-kit receptor are kinase independent and imatinib insensitive.
Tabone-Eglinger S; Calderin-Sollet Z; Pinon P; Aebischer N; Wehrle-Haller M; Jacquier MC; Boettiger D; Wehrle-Haller B
FASEB J; 2014 Oct; 28(10):4441-56. PubMed ID: 25002122
[TBL] [Abstract][Full Text] [Related]
16. Fyn kinase acts upstream of Shp2 and p38 mitogen-activated protein kinase to promote chemotaxis of mast cells towards stem cell factor.
Samayawardhena LA; Hu J; Stein PL; Craig AW
Cell Signal; 2006 Sep; 18(9):1447-54. PubMed ID: 16442778
[TBL] [Abstract][Full Text] [Related]
17. Quercetin inhibits expression of inflammatory cytokines through attenuation of NF-kappaB and p38 MAPK in HMC-1 human mast cell line.
Min YD; Choi CH; Bark H; Son HY; Park HH; Lee S; Park JW; Park EK; Shin HI; Kim SH
Inflamm Res; 2007 May; 56(5):210-5. PubMed ID: 17588137
[TBL] [Abstract][Full Text] [Related]
18. RabGEF1 regulates stem cell factor/c-Kit-mediated signaling events and biological responses in mast cells.
Kalesnikoff J; Rios EJ; Chen CC; Nakae S; Zabel BA; Butcher EC; Tsai M; Tam SY; Galli SJ
Proc Natl Acad Sci U S A; 2006 Feb; 103(8):2659-64. PubMed ID: 16533754
[TBL] [Abstract][Full Text] [Related]
19. Distinct signalling pathways for mutated KIT(V560G) and KIT(D816V) in mastocytosis.
Chan IJ; Kasprowicz S; Tharp MD
Clin Exp Dermatol; 2013 Jul; 38(5):538-44. PubMed ID: 23777495
[TBL] [Abstract][Full Text] [Related]
20. C-kit mutations and PKC crosstalks: PKC translocates to nucleous only in cells HMC⁵⁶⁰,⁸¹⁶.
Tobío A; Alfonso A; Botana LM
J Cell Biochem; 2011 Sep; 112(9):2637-51. PubMed ID: 21598306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
